Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Confirmation of Artemisinin Tolerance in Malaria Parasites Trial in Kilifi

NCT01190371 is registered in ClinicalTrials.gov with KEMRI-Wellcome Trust Collaborative Research Program as lead sponsor.

NCT NCT01190371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01190371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Confirmation of Artemisinin Tolerance in Malaria Parasites Trial in Kilifi
Lead sponsor
KEMRI-Wellcome Trust Collaborative Research Program
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2011
Completion date
December 31, 2018
Enrollment
175 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malaria